Effects of Angiotensin-Converting Enzyme Inhibitor on Delayed-Onset Doxorubicin-Induced Cardiotoxicity

By Boucek Robert J.   Steele Ann   Miracle Ann   Atkinson James  

Cardiovascular Toxicology, Vol. 3, Iss. 4, 2003-12 ,pp. : 319-330

Humana Press, Inc

Access to resources Recommend Favorite

What is the association of acute renal failure, angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker in a young patient?

By Yüksel Selçuk   Koçyiğit Ali   Uzun Ebru   Tepeli Emre   Özcan Vefa   Becerir Tülay  

Clinical Kidney Journal, Vol. 6, Iss. 1, 2013-02 ,pp. : 98-99

Oxford University Press

Access to resources Recommend Favorite

Aspirin, beta-blocker and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction

By Berger A.K.   Duval S.   Krumholz H.M.  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 17-17

Elsevier

Access to resources Recommend Favorite

Angiotensin-converting enzyme (ACE) inhibitor therapy after myocardial infarction in relation to left ventricular function

By Reikvam Aasmund   Kvan Elena   Landmark Knud   Aursnes Ivar  

Scandinavian Cardiovascular Journal, Vol. 37, Iss. 3, 2003-01 ,pp. : 130-134

Informa Healthcare

Access to resources Recommend Favorite

Letter to the Editor 'Effects of the angiotensin-converting enzyme inhibitor perindopril on endothelial and platelet function in essential hypertension'

By Jagroop I. A.   Papadakis J. A.   Mikhailidis D. P.  

Platelets, Vol. 9, Iss. 6, 1998-12 ,pp. : 395-396

Informa Healthcare

Access to resources Recommend Favorite